Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM

被引：0
|
作者：
Everage, Nicholas J. [1 ]
Prada, Claudia [1 ]
Liu, Shifang [1 ]
Balashov, Konstantin [2 ]
Macdonell, Richard [3 ]
Windsheimer, Jorg [4 ]
Giles, Kathryn [5 ]
机构：
[1] Biogen, Cambridge, MA USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[3] Univ Melbourne, Austin Hlth, Dept Neurol, Melbourne, Vic, Australia
[4] Praxis Neurol & Psychiat, Nurnberg, Germany
[5] Cambridge Mem Hosp, Cambridge, ON, Canada
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.333
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis patients with cardiovascular disease: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Havrdova, E.
    Fox, R. J.
    Gold, R.
    Li, J.
    Zhang, A.
    Potts, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 551 - 552
  • [32] Absolute Lymphocyte Count in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Delayed-release Dimethyl Fumarate: Considerations for Patient Management
    Fox, Robert
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Prada, Claudia
    Ray, Soma
    Mehta, Devangi
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [33] Efficacy of delayed-release dimethyl fumarate in Japanese patients with relapsing multiple sclerosis in the placebo-controlled phase 3 apex study
    Kondo, T.
    Kawachi, I.
    Onizuka, Y.
    Hiramatsu, K.
    Hase, M.
    Yun, J.
    Ling, Y.
    Torii, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 439 - 440
  • [34] Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Fox, Robert J.
    Kappos, Ludwig
    Chen, Chongshu
    Parks, Becky
    Miller, Catherine
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [35] COST-EFFECTIVENESS ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMARATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gasche, D.
    Restovic, G.
    Casado, V
    Ramirez-Boix, P.
    Martinez Lopez, J.
    VALUE IN HEALTH, 2015, 18 (07) : A755 - A755
  • [36] Delayed-release dimethyl fumarate and disability assessed by the multiple sclerosis functional composite: integrated analysis of DEFINE and CONFIRM
    Giovannoni, G.
    Gold, R.
    Kappos, L.
    Arnold, D. L.
    Bar-Or, A.
    Kurukulasuriya, N. C.
    Yang, M.
    Sarda, S. P.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 92 - 92
  • [37] Effect of aspirin on flushing in relapsing-remitting multiple sclerosis patients receiving delayed-release dimethyl fumarate
    Rog, D.
    Cader, S.
    Harrower, T.
    McGuigan, C.
    Young, C.
    Potts, J.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 656 - 657
  • [38] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    Neurology and Therapy, 2020, 9 : 85 - 92
  • [39] Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
    Lori Mayer
    Mary Kay Fink
    Carrie Sammarco
    Lisa Laing
    Drug Safety, 2018, 41 : 347 - 356
  • [40] Pregnancy Outcomes From an International Registry of Patients Treated With Delayed-release Dimethyl Fumarate
    Everage, Nicholas J.
    Jones, Cynthia C.
    Hellwig, Kerstin
    Rog, David
    Liu, Shifang
    Mou, Jiani
    Prada, Claudia
    Hanna, Jerome
    NEUROLOGY, 2019, 92 (15)
12345